Skip to main content
Livermore
Livermore
ZHEN

Walleye Capital LLC

SEC CIK
0001758720
Latest filing
Aug 3, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
335
Value
$166.4K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VRTX by Walleye Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026335$166.4K<0.1%−30,417−98.9%ReducedHolders
Q1 202630,752$13.7M0.1%+15,778+105.4%AddedHolders
Q4 202514,974$6.79M<0.1%+12,512+508.2%AddedHolders
Q3 20252,462$964.2K<0.1%+2,130+641.6%AddedHolders
Q2 2025332$147.8K<0.1%−3,071−90.2%ReducedHolders
Q1 20253,403$1.65M<0.1%+3,225+1,811.8%AddedHolders
Q4 2024178$71.7K<0.1%−5,203−96.7%ReducedHolders
Q3 20245,381$2.50M<0.1%+2,596+93.2%AddedHolders
Q2 20242,785$1.31M<0.1%−54−1.9%ReducedHolders
Q1 20242,839$1.19M<0.1%−9,416−76.8%ReducedHolders
Q4 202312,255$4.99M0.1%−14,090−53.5%ReducedHolders
Q3 202326,345$9.16M0.1%+26,345NewHolders
Q2 20230$00.0%−9,328−100.0%Sold outHolders
Q1 20239,328$2.94M0.1%−46,509−83.3%ReducedHolders
Q4 202255,837$16.1M0.4%−11,186−16.7%ReducedHolders
Q3 202267,023$19.4M0.4%+37,649+128.2%AddedHolders
Q2 202229,374$8.28M0.2%+16,634+130.6%AddedHolders
Q1 202212,740$3.33M0.1%−18,463−59.2%ReducedHolders
Q4 202131,203$6.85M0.2%+2,373+8.2%AddedHolders
Q3 202128,830$5.23M0.2%−2,601−8.3%ReducedHolders
Q2 202131,431$6.34M0.2%+29,963+2,041.1%AddedHolders
Q1 20211,468$315.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.